Terns Pharmaceuticals, Inc. (TERN)
Delisted
15 May 2026
NASDAQ (NGS) NASDAQ (NGS) Primary 
XSTU $
52. 95
-0.02
-0.0321%
After Hours
$
+14.85 +28.0453% 67. 80
4.77B Market Cap
- P/E Ratio
- Div Yield
6.33M Volume
-1.33 Eps
$ 52.97
Previous Close Investors:
Day Range
52.95 52.97
Year Range
2.65 53.19
Want to track TERN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Terns Pharmaceuticals, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 370 | $5,526.16 | $19,506 | $13,979.84 | 252.98% |
 Bobby Adusumilli SJS Investment Consulting Inc. | 9 | $0.48 | $0.48 | - | - |
 Mathieu Cornu Pictet Asset Management Holding SA | 1.66M | $31.54M | $12.43M | -$19.11M | -60.58% |
| RFL Rossby Financial LLC Rossby Financial LLC | 124 | $6,546 | $6,546 | - | - |
 Charles Hillier Cibra Capital Ltd. | 151,440 | $7.98M | $7.98M | - | - |
